http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104592148-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_159936a9a847e1b85fb4d921ae15d764 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bcb4ce2c07706533757f51b0f91eaf8 |
publicationDate | 2015-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104592148-A |
titleOfInvention | A class of nitrobenzothiazole carboxylic acid amide compounds containing cyclopropylamidine structure and its application |
abstract | The invention relates to the field of medicine related to type 2 diabetes. Specifically, the present invention relates to a class of non-glycoside SGLT2/SGLT1 dual-target inhibitors containing nitrobenzothiazole carboxylic acid amide containing cyclopropylamidine structure, its preparation method and their application in the preparation of type 2 diabetes drugs . |
priorityDate | 2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.